Mohammad Al-Essa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mohammad Al-Essa has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Saif Aldeen AlRyalat
Department of Ophthalmology, University of Illinois Chicago, 1905 W Taylor St, Chicago, IL 60612, USA; Department of ophthalmology, The University of Jordan, Queen Rania St, Amman 11942, Jordan
4 shared publications Ahmad Alkilany
Department of Internal Medicine, The University of Jordan, Amman 11942, Jordan
1 shared publicationAnas Abu Nassar
King Hussein Cancer Center, 11942 Amman, Jordan
1 shared publication- Ashraf O. Oweis
School of Medicine, Jordan University of Science and Technology, Ramtha 22110, Jordan
1 shared publication Dia Mobaideen
4th Year Internal Medicine Resident, University of Jordan Hospital, University of Jordan, Amman, Jordan
1 shared publicationEnas Abusalim
4th Year Internal Medicine Resident, University of Jordan Hospital, University of Jordan, Amman, Jordan
1 shared publication
Latest Publications
- Open Access
- 12 September 2019
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 15 (1) , 26-31
The Impact of Open-Access Status on Journal Indices: Respiratory and Pulmonology Journals
Background: Open access (OA) publishing is rapidly emerging in almost all disciplines, with variable intensity and effect on the discipline itself. The move toward OA is also observed in the field of respiratory and pulmonology, where both OA data repositories and OA journals are rapidly emerging. Objective: we aim to study the open-access status of respiratory and pulmonology journals and the impact of the open-access status on journal indices. Methods: We collected journal’s data from Scopus Source List on 1st of November 2018. We filtered the list for respiratory and pulmonology journals. Open Access Journals covered by Scopus are recognized as Open Access if the journal is listed in the Directory of Open Access Journals (DOAJ) and/or the Directory of Open Access Scholarly Resources (ROAD). For each journal, we used several metrics to measure its strength, and then we compared these metrics between OA and non- OA journals. Results: There were 125 respiratory and pulmonology journals, a number that has increased by 12.6% since 2011. Moreover, the percentage of OA journals has increased from 21.6% to 26.4% during the same period. Non-OA journals have significantly higher scholarly output (p= 0.033), but OA journals have significantly higher percentage of citation (p= 0.05). Conclusion: Publishing in OA journals will yield a higher citation percentage compared to non-OA journals. Although this should not be the only reason to publish in an OA journal, it is still an important factor to decide where to publish.
- 12 September 2019
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 15 (1) , 26-31
Open AccessThe Impact of Open-Access Status on Journal Indices: Respiratory and Pulmonology Journals
Background: Open access (OA) publishing is rapidly emerging in almost all disciplines, with variable intensity and effect on the discipline itself. The move toward OA is also observed in the field of respiratory and pulmonology, where both OA data repositories and OA journals are rapidly emerging. Objective: we aim to study the open-access status of respiratory and pulmonology journals and the impact of the open-access status on journal indices. Methods: We collected journal’s data from Scopus Source List on 1st of November 2018. We filtered the list for respiratory and pulmonology journals. Open Access Journals covered by Scopus are recognized as Open Access if the journal is listed in the Directory of Open Access Journals (DOAJ) and/or the Directory of Open Access Scholarly Resources (ROAD). For each journal, we used several metrics to measure its strength, and then we compared these metrics between OA and non- OA journals. Results: There were 125 respiratory and pulmonology journals, a number that has increased by 12.6% since 2011. Moreover, the percentage of OA journals has increased from 21.6% to 26.4% during the same period. Non-OA journals have significantly higher scholarly output (p= 0.033), but OA journals have significantly higher percentage of citation (p= 0.05). Conclusion: Publishing in OA journals will yield a higher citation percentage compared to non-OA journals. Although this should not be the only reason to publish in an OA journal, it is still an important factor to decide where to publish.
- Open Access
- 1 April 2019
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 12, 575-579
Prevalence of metabolic syndrome in dialysis and transplant patients
Background: Several epidemiological studies have assessed various components of Metabolic Syndrome (MS) in different populations, but only a few compared the prevalence of metabolic syndrome in dialysis and transplant patients. Aim: The aim of this study is to compare the prevalence of MS in dialysis and transplant patients. Two groups of patients were included; hemodialysis patients and patients with transplanted kidneys. Methods: Demographic and clinical history, and lab data were collected. A total of 108 patients were included in this study with a mean age of 52.3 (±16.29) years. Study groups included 61 (56.5%) dialysis patients, and 47 (43.5%) patients with transplanted kidneys. Results: Upon comparing the prevalence of metabolic syndrome between the two study groups, transplant patients had significantly lower prevalence of metabolic syndrome (34%) compared to that of metabolic syndrome in patients on dialysis (55.7%; P=0.016). Conclusion: As metabolic syndrome plays an important role in the pathology of elderly patients, especially those with transplanted kidneys, such findings indicate the need for close monitoring of kidney transplant patients for the manifestations of metabolic syndrome.
- 1 April 2019
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 12, 575-579
Open AccessPrevalence of metabolic syndrome in dialysis and transplant patients
Background: Several epidemiological studies have assessed various components of Metabolic Syndrome (MS) in different populations, but only a few compared the prevalence of metabolic syndrome in dialysis and transplant patients. Aim: The aim of this study is to compare the prevalence of MS in dialysis and transplant patients. Two groups of patients were included; hemodialysis patients and patients with transplanted kidneys. Methods: Demographic and clinical history, and lab data were collected. A total of 108 patients were included in this study with a mean age of 52.3 (±16.29) years. Study groups included 61 (56.5%) dialysis patients, and 47 (43.5%) patients with transplanted kidneys. Results: Upon comparing the prevalence of metabolic syndrome between the two study groups, transplant patients had significantly lower prevalence of metabolic syndrome (34%) compared to that of metabolic syndrome in patients on dialysis (55.7%; P=0.016). Conclusion: As metabolic syndrome plays an important role in the pathology of elderly patients, especially those with transplanted kidneys, such findings indicate the need for close monitoring of kidney transplant patients for the manifestations of metabolic syndrome.
- Open Access
- 1 January 2019
- Published by Taylor & Francis in Open Access Rheumatology: Research and Reviews
- Vol. ume 11, 11-18
Correlation between Xerostomia index, Clinical Oral Dryness Scale, and ESSPRI with different hyposalivation tests
Background and objective: Xerostomia is a subjective measure of dry mouth, while hyposalivation is an objective measure of reduced saliva flow rate. In this study, we aim to assess the association between commonly used xerostomia scoring systems, with different hyposalivation measures among Sjogren Syndrome (SS) patients. Methods: In a cohort of SS patients, we assessed xerostomia using Xerostomia index, clinical oral dryness scale (CODS), and the European League Against Rheumatism SS Patient-Reported Index (ESSPRI), and we assessed hyposalivation using unstimulated whole saliva flow (UWS), stimulated whole saliva flow (SWS), and stimulated parotid flow (SPF). We analyzed the association between xerostomia and hyposalivation using association tests in SPSS. Results: We included a total of 49 patients in this study, of which 34 (68%) had primary SS, and 15 (32%) had secondary. CODS was significantly correlated with SWS (P=0.048), with a negative correlation coefficient of 0.216, and with SPF (P=0.009), with a negative correlation coefficient of 0.291. The dryness domain of ESSPRI was significantly correlated with UWS (P=0.031) with a negative correlation coefficient of 0.233. Conclusion: CODS is the scoring system with the highest correlation with hyposalivation, particularly SWS and SPF, followed by ESSPRI dry domain, which is correlated with UWS. Xerostomia index is not correlated with hyposalivation.
- 1 January 2019
- Published by Taylor & Francis in Open Access Rheumatology: Research and Reviews
- Vol. ume 11, 11-18
Open AccessCorrelation between Xerostomia index, Clinical Oral Dryness Scale, and ESSPRI with different hyposalivation tests
Background and objective: Xerostomia is a subjective measure of dry mouth, while hyposalivation is an objective measure of reduced saliva flow rate. In this study, we aim to assess the association between commonly used xerostomia scoring systems, with different hyposalivation measures among Sjogren Syndrome (SS) patients. Methods: In a cohort of SS patients, we assessed xerostomia using Xerostomia index, clinical oral dryness scale (CODS), and the European League Against Rheumatism SS Patient-Reported Index (ESSPRI), and we assessed hyposalivation using unstimulated whole saliva flow (UWS), stimulated whole saliva flow (SWS), and stimulated parotid flow (SPF). We analyzed the association between xerostomia and hyposalivation using association tests in SPSS. Results: We included a total of 49 patients in this study, of which 34 (68%) had primary SS, and 15 (32%) had secondary. CODS was significantly correlated with SWS (P=0.048), with a negative correlation coefficient of 0.216, and with SPF (P=0.009), with a negative correlation coefficient of 0.291. The dryness domain of ESSPRI was significantly correlated with UWS (P=0.031) with a negative correlation coefficient of 0.233. Conclusion: CODS is the scoring system with the highest correlation with hyposalivation, particularly SWS and SPF, followed by ESSPRI dry domain, which is correlated with UWS. Xerostomia index is not correlated with hyposalivation.
- 27 April 2018
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 13 (4) , 241-246
Chest X-ray in Sarcoidosis: The Association of Age, Gender, and Ethnicity with Different Radiological Findings
Background: Sarcoidosis is a granulomatous disease that primarily affects the lung and lymphatic systems of the body. The Chest X-ray (Roentgenology) is the most common first imaging modality used in the diagnostic approach and follow-up of sarcoidosis, and is still used to determine the stage of sarcoidois based on the classification system proposed by Scadding (1961). Objective: We will assess the relation between different chest x-ray findings in sarcoidosis patients and both, demographic variables of sarcoidosis patients (age, gender, and race), along with different Scadding stages. Method: We included data regarding cases in the case-control ACCESS study, including demographic and clinical data, in addition to X-ray findings. From those with a biopsy-confirmed diagnosis of sarcoidosis in the ACCESS trial, we excluded patients with diseases that might contribute to X-ray abnormalities, including cardiac and respiratory non-sarcoidosis diseases (e.g. asthma and chronic bronchitis). We also excluded sarcoidosis patients without lung involvement. Results: A total of 499 patients were included in this study, of which 195 (39.1%) were men and 304 (60.9%) were women. We found that pleural abnormalities are most commonly associated with Scadding stage 2 (42.9%, p= 0.001), whereas Scadding stage 4 is associated with hilar retraction (52.8%, p< 0.001), bullae and bleps (73.7%, p< 0.001), and pulmonary artery enlargement (66.7%, p< 0.001). Finally, we also observed significant relations between demographic variables (age, gender, and race) and different imaging findings. Conclusion: Upon interpreting chest X-ray of sarcoidosis patients, patients' age, gender, and race should be kept in mind, as demographic variables are associated with chest X-ray findings in those patients. Moreover, each Scadding stage is associated with several findings on chest X-ray in sarcoidosis patients and should be interpreted accordingly.
- 27 April 2018
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 13 (4) , 241-246
Chest X-ray in Sarcoidosis: The Association of Age, Gender, and Ethnicity with Different Radiological Findings
Background: Sarcoidosis is a granulomatous disease that primarily affects the lung and lymphatic systems of the body. The Chest X-ray (Roentgenology) is the most common first imaging modality used in the diagnostic approach and follow-up of sarcoidosis, and is still used to determine the stage of sarcoidois based on the classification system proposed by Scadding (1961). Objective: We will assess the relation between different chest x-ray findings in sarcoidosis patients and both, demographic variables of sarcoidosis patients (age, gender, and race), along with different Scadding stages. Method: We included data regarding cases in the case-control ACCESS study, including demographic and clinical data, in addition to X-ray findings. From those with a biopsy-confirmed diagnosis of sarcoidosis in the ACCESS trial, we excluded patients with diseases that might contribute to X-ray abnormalities, including cardiac and respiratory non-sarcoidosis diseases (e.g. asthma and chronic bronchitis). We also excluded sarcoidosis patients without lung involvement. Results: A total of 499 patients were included in this study, of which 195 (39.1%) were men and 304 (60.9%) were women. We found that pleural abnormalities are most commonly associated with Scadding stage 2 (42.9%, p= 0.001), whereas Scadding stage 4 is associated with hilar retraction (52.8%, p< 0.001), bullae and bleps (73.7%, p< 0.001), and pulmonary artery enlargement (66.7%, p< 0.001). Finally, we also observed significant relations between demographic variables (age, gender, and race) and different imaging findings. Conclusion: Upon interpreting chest X-ray of sarcoidosis patients, patients' age, gender, and race should be kept in mind, as demographic variables are associated with chest X-ray findings in those patients. Moreover, each Scadding stage is associated with several findings on chest X-ray in sarcoidosis patients and should be interpreted accordingly.